Pemvidutide
Category: Dual GLP-1/Glucagon Agonist
Dual agonist being studied for NASH and obesity with liver-focused benefits.
Half-Life: 120 hours
Benefits
- Liver fat reduction
- Weight loss
- NASH improvement in trials
- Metabolic benefits
Side Effects
- GI effects
- Nausea
- Blood pressure changes